Videos

In a recent interview at the RSNA conference, Constance Lehman, M.D., Ph.D., discussed new research, which compared image-based AI for mammography versus breast density assessment in evaluating breast cancer risk.

In a recent interview, Stamatia Destounis, M.D., discussed new research, which showed that over 20 percent of breast cancer was detected in women under 50 years of age and that 80 percent of these cases involved invasive breast cancer.

Catch up on the top radiology content of the past week.

Deep learning assessment of adrenal gland volume on computed tomography (CT) scans may provide an objective assessment of chronic stress with significant links to adverse cardiovascular outcomes, according to new research to be presented at the Radiological Society of North America (RSNA) annual meeting.

In a recent interview, Nina Kottler, M.D., discussed key trends that are leading to a renewed focus on improved enterprise imaging platforms and the potential promise of integrating Cognita Imaging’s Mosaic Drafting vision language model technology into the MosaicOS platform.

Catch up on the top radiology content of the past week.

In a recent interview, Christoph Lee, M.D., discussed key findings from the ASSURE study, which evaluated the use of AI in detection and triage in a multicenter trial involving over 579,000 women who had digital breast tomosynthesis (DBT) exams.

Catch up on the top radiology content of the past week.

In a recent interview, Ibrahim Danad, M.D., Ph.D., discussed new research findings from the multicenter CONFIRM2 trial and use of the AI-CT software to obtain automated quantification of plaque burden based off coronary computed tomography angiography (CCTA) scans.

In a recent interview, Timothy Fairbairn, Ph.D., and Fatima Rodiguez, M.D., discussed new research findings, recently presented at the American Heart Association (AHA) conference, showing the value of AI-powered quantification of plaque burden from CCTA exams for predicting adverse cardiovascular outcomes.

Catch up on the top radiology content of the past week.

In a recent interview, Hari Kishan Gonuguntla, M.D., discussed AI-powered evaluation of chest X-rays with the Lung Nodule Malignancy Score software and key findings from multinational prospective research presented at the recent ESMO Congress 2025 meeting.

In the second part of a recent interview on new molecular imaging guidelines for renal masses, Steven Rowe, M.D., discussed the off-label utility of the mitochondrial imaging agent 99mTc-sestamibi and the potential role of AI in advanced imaging for indeterminate renal masses.

In a recent interview, Steven Rowe, M.D., discussed pertinent insights from recently published molecular imaging guidelines for renal masses and the potential of 89Zr-girentuximab for clear cell renal cell carcinoma (ccRCC).

Catch up on the top radiology content of the past week.

The AI-enabled e-Lung software may lead to significantly improved and earlier detection of progressive pulmonary fibrosis, even in patients deemed clinically stable, according to new research recently presented at the American College of Chest Physicians (CHEST) conference.

Catch up on the top radiology content of the past week.

Use of the radiotherapeutic agent 177Lu-edotreotide (ITM-11) demonstrated significantly higher absorption in gastroenteropancreatic neuroendocrine tumors than normal organs along with a favorable safety profile, according to SPECT research recently presented at the European Association of Nuclear Medicine (EANM) conference.

In a recent interview, Deepa Sheth, M.D., discussed the rising incidence of breast cancer, key considerations in supplemental imaging for women with dense breasts and use of the CIVIE RadPod platform to facilitate consistent quality and imaging reads by fellowship-trained breast radiologists.

Catch up on the top radiology content of the past week.

In the second part of a recent interview, Emmanuel S. Antonarakis, M.D. discusses PSMA PET agents in current trials and cell surface proteins that may offer targeting utility in prostate cancer imaging beyond PSMA.

Through enhanced data interoperability and access to patient histories, the cloud-based InteleHeart may facilitate better communication and workflow efficiencies for radiologists and cardiologists.

Catch up on the top radiology content of the past week.

In a recent interview, Morris Panner offered his perspective on cultural hurdles to interoperability in health care, emerging trends with enterprise imaging and an answer first approach to integrating AI in radiology.

In a recent interview, Arthy Saravanan, M.D., discussed the recent launch of the Mammo Enhance Heart program from Radiology Partners and its potential impact in facilitating dual screening for breast cancer and cardiovascular risk.

In a recent interview, Emmanuel S. Antonarakis, M.D. discussed contributing factors to the recent American Cancer Society report about rising prostate cancer incidence and offered insights about the potential role of the radioligand agent 177Lu-PSMA-I&T for patients with mCRPC.

In a recent interview, Manisha Bahl, M.D., discussed new research showing significant associations between AI detection and the histologic grade and lymph node status of breast cancer.

Catch up on the top radiology content of the past week.

For patients with relapsing multiple sclerosis, switching from oral therapies to subcutaneous monthly administration of the anti-CD20 monoclonal antibody ofatumumab led to over a 98 percent reduction of Gd+ T1 lesions on MRI at 96 weeks.

In a recent interview, Partho Sengupta, M.D., and Davinder Ramsingh, Ph.D., discussed recent research demonstrating the capability of point-of-care ultrasound (POCUS) to facilitate reduced length of stay and significant cost savings in the management of patients with dyspnea.